메뉴 건너뛰기




Volumn 80, Issue 4, 2014, Pages 545-553

The effect of chronic twice daily exenatide treatment on β-cell function in new onset type 2 diabetes

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; EXENDIN 4; GLUCOSE; HEMOGLOBIN A1C; INSULIN; PLACEBO;

EID: 84896784072     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/cen.12199     Document Type: Article
Times cited : (21)

References (32)
  • 1
    • 33644618433 scopus 로고    scopus 로고
    • The biology of incretin hormones
    • Drucker, D.J., (2006) The biology of incretin hormones. Cell Metabolism, 3, 153-165.
    • (2006) Cell Metabolism , vol.3 , pp. 153-165
    • Drucker, D.J.1
  • 2
    • 33846006173 scopus 로고    scopus 로고
    • The incretin system: Glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes
    • Drucker, D.J., &, Nauck, M.A., (2006) The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes. Lancet, 368, 1696-1705.
    • (2006) Lancet , vol.368 , pp. 1696-1705
    • Drucker, D.J.1    Nauck, M.A.2
  • 4
    • 0043169338 scopus 로고    scopus 로고
    • Differential effects of acute and extended infusions of glucagon-like peptide-1 on first- and second-phase insulin secretion in diabetic and nondiabetic humans
    • Quddusi, S., Vahl, T.P., Hanson, K., et al,. (2003) Differential effects of acute and extended infusions of glucagon-like peptide-1 on first- and second-phase insulin secretion in diabetic and nondiabetic humans. Diabetes Care, 26, 791-798.
    • (2003) Diabetes Care , vol.26 , pp. 791-798
    • Quddusi, S.1    Vahl, T.P.2    Hanson, K.3
  • 5
    • 0029909112 scopus 로고    scopus 로고
    • Normalization of insulin responses to glucose by overnight infusion of glucagon-like peptide 1 (7-36) amide in patients with NIDDM
    • Rachman, J., Gribble, F.M., Barrow, B.A., et al,. (1996) Normalization of insulin responses to glucose by overnight infusion of glucagon-like peptide 1 (7-36) amide in patients with NIDDM. Diabetes, 45, 1524-1530.
    • (1996) Diabetes , vol.45 , pp. 1524-1530
    • Rachman, J.1    Gribble, F.M.2    Barrow, B.A.3
  • 6
    • 0035082496 scopus 로고    scopus 로고
    • Glucagon-like peptide 1 increases secretory burst mass of pulsatile insulin secretion in patients with type 2 diabetes and impaired glucose tolerance
    • Ritzel, R., Schulte, M., Porksen, N., et al,. (2001) Glucagon-like peptide 1 increases secretory burst mass of pulsatile insulin secretion in patients with type 2 diabetes and impaired glucose tolerance. Diabetes, 50, 776-784.
    • (2001) Diabetes , vol.50 , pp. 776-784
    • Ritzel, R.1    Schulte, M.2    Porksen, N.3
  • 8
    • 0036965113 scopus 로고    scopus 로고
    • The insulinotropic effect of acute exendin-4 administered to humans: Comparison of nondiabetic state to type 2 diabetes
    • Egan, J.M., Clocquet, A.R., &, Elahi, D., (2002) The insulinotropic effect of acute exendin-4 administered to humans: comparison of nondiabetic state to type 2 diabetes. Journal of Clinical Endocrinology and Metabolism, 87, 1282-1290.
    • (2002) Journal of Clinical Endocrinology and Metabolism , vol.87 , pp. 1282-1290
    • Egan, J.M.1    Clocquet, A.R.2    Elahi, D.3
  • 9
    • 27744541052 scopus 로고    scopus 로고
    • Exenatide augments first- and second-phase insulin secretion in response to intravenous glucose in subjects with type 2 diabetes
    • Fehse, F., Trautmann, M., Holst, J.J., et al,. (2005) Exenatide augments first- and second-phase insulin secretion in response to intravenous glucose in subjects with type 2 diabetes. Journal of Clinical Endocrinology and Metabolism, 90, 5991-5997.
    • (2005) Journal of Clinical Endocrinology and Metabolism , vol.90 , pp. 5991-5997
    • Fehse, F.1    Trautmann, M.2    Holst, J.J.3
  • 10
    • 56549107405 scopus 로고    scopus 로고
    • Effect of exenatide on gastric emptying and relationship to postprandial glycemia in type 2 diabetes
    • Linnebjerg, H., Park, S., Kothare, P.A., et al,. (2008) Effect of exenatide on gastric emptying and relationship to postprandial glycemia in type 2 diabetes. Regulatory Peptides, 151, 123-129.
    • (2008) Regulatory Peptides , vol.151 , pp. 123-129
    • Linnebjerg, H.1    Park, S.2    Kothare, P.A.3
  • 11
    • 53249142132 scopus 로고    scopus 로고
    • Exenatide once weekly versus twice daily for the treatment of type 2 diabetes: A randomised, open-label, non-inferiority study
    • Drucker, D.J., Buse, J.B., Taylor, K., et al,. (2008) Exenatide once weekly versus twice daily for the treatment of type 2 diabetes: a randomised, open-label, non-inferiority study. Lancet, 372, 1240-1250.
    • (2008) Lancet , vol.372 , pp. 1240-1250
    • Drucker, D.J.1    Buse, J.B.2    Taylor, K.3
  • 12
    • 34447267513 scopus 로고    scopus 로고
    • Efficacy and safety of incretin therapy in type 2 diabetes: Systematic review and meta-analysis
    • Amori, R.E., Lau, J., &, Pittas, A.G., (2007) Efficacy and safety of incretin therapy in type 2 diabetes: systematic review and meta-analysis. JAMA, 298, 194-206.
    • (2007) JAMA , vol.298 , pp. 194-206
    • Amori, R.E.1    Lau, J.2    Pittas, A.G.3
  • 13
    • 79956336447 scopus 로고    scopus 로고
    • Effect of Exenatide on Splanchnic and Peripheral Glucose Metabolism in Type 2 Diabetic Subjects
    • Cersosimo, E., Gastaldelli, A., Cervera, A., et al,. (2011) Effect of Exenatide on Splanchnic and Peripheral Glucose Metabolism in Type 2 Diabetic Subjects. Journal of Clinical Endocrinology and Metabolism, 96, 1763-1770.
    • (2011) Journal of Clinical Endocrinology and Metabolism , vol.96 , pp. 1763-1770
    • Cersosimo, E.1    Gastaldelli, A.2    Cervera, A.3
  • 14
    • 80052517174 scopus 로고    scopus 로고
    • Glucagon-like peptide-1 receptor activation stimulates hepatic lipid oxidation and restores hepatic signalling alteration induced by a high-fat diet in nonalcoholic steatohepatitis
    • Svegliati-Baroni, G., Saccomanno, S., Rychlicki, C., et al,. (2011) Glucagon-like peptide-1 receptor activation stimulates hepatic lipid oxidation and restores hepatic signalling alteration induced by a high-fat diet in nonalcoholic steatohepatitis. Liver International, 31, 1285-1297.
    • (2011) Liver International , vol.31 , pp. 1285-1297
    • Svegliati-Baroni, G.1    Saccomanno, S.2    Rychlicki, C.3
  • 15
    • 0038497464 scopus 로고    scopus 로고
    • Synthetic exendin-4 (exenatide) significantly reduces postprandial and fasting plasma glucose in subjects with type 2 diabetes
    • Kolterman, O.G., Buse, J.B., Fineman, M.S., et al,. (2003) Synthetic exendin-4 (exenatide) significantly reduces postprandial and fasting plasma glucose in subjects with type 2 diabetes. Journal of Clinical Endocrinology and Metabolism, 88, 3082-3089.
    • (2003) Journal of Clinical Endocrinology and Metabolism , vol.88 , pp. 3082-3089
    • Kolterman, O.G.1    Buse, J.B.2    Fineman, M.S.3
  • 16
    • 33845968872 scopus 로고    scopus 로고
    • Mathematical modeling shows exenatide improved beta-cell function in patients with type 2 diabetes treated with metformin or metformin and a sulfonylurea
    • Mari, A., Nielsen, L.L., Nanayakkara, N., et al,. (2006) Mathematical modeling shows exenatide improved beta-cell function in patients with type 2 diabetes treated with metformin or metformin and a sulfonylurea. Hormone and Metabolic Research, 38, 838-844.
    • (2006) Hormone and Metabolic Research , vol.38 , pp. 838-844
    • Mari, A.1    Nielsen, L.L.2    Nanayakkara, N.3
  • 17
    • 51549095571 scopus 로고    scopus 로고
    • Efficacy and tolerability of exenatide monotherapy over 24 weeks in antidiabetic drug-naive patients with type 2 diabetes: A randomized, double-blind, placebo-controlled, parallel-group study
    • Moretto, T.J., Milton, D.R., Ridge, T.D., et al,. (2008) Efficacy and tolerability of exenatide monotherapy over 24 weeks in antidiabetic drug-naive patients with type 2 diabetes: a randomized, double-blind, placebo-controlled, parallel-group study. Clinical Therapeutics, 30, 1448-1460.
    • (2008) Clinical Therapeutics , vol.30 , pp. 1448-1460
    • Moretto, T.J.1    Milton, D.R.2    Ridge, T.D.3
  • 18
    • 0035089445 scopus 로고    scopus 로고
    • A model-based method for assessing insulin sensitivity from the oral glucose tolerance test
    • Mari, A., Pacini, G., Murphy, E., et al,. (2001) A model-based method for assessing insulin sensitivity from the oral glucose tolerance test. Diabetes Care, 24, 539-548.
    • (2001) Diabetes Care , vol.24 , pp. 539-548
    • Mari, A.1    Pacini, G.2    Murphy, E.3
  • 19
    • 0026504160 scopus 로고
    • Estimation of insulin secretion rates from C-peptide levels Comparison of individual and standard kinetic parameters for C-peptide clearance
    • Van Cauter, E., Mestrez, F., Sturis, J., et al,. (1992) Estimation of insulin secretion rates from C-peptide levels Comparison of individual and standard kinetic parameters for C-peptide clearance. Diabetes, 41, 368-377.
    • (1992) Diabetes , vol.41 , pp. 368-377
    • Van Cauter, E.1    Mestrez, F.2    Sturis, J.3
  • 20
    • 33846031943 scopus 로고    scopus 로고
    • Muscle and liver insulin resistance indexes derived from the oral glucose tolerance test
    • Abdul-Ghani, M.A., Matsuda, M., Balas, B., et al,. (2007) Muscle and liver insulin resistance indexes derived from the oral glucose tolerance test. Diabetes Care, 30, 89-94.
    • (2007) Diabetes Care , vol.30 , pp. 89-94
    • Abdul-Ghani, M.A.1    Matsuda, M.2    Balas, B.3
  • 21
    • 0942279564 scopus 로고    scopus 로고
    • Beta-cell dysfunction and glucose intolerance: Results from the San Antonio metabolism (SAM) study
    • Gastaldelli, A., Ferrannini, E., Miyazaki, Y., et al,. (2004) Beta-cell dysfunction and glucose intolerance: results from the San Antonio metabolism (SAM) study. Diabetologia, 47, 31-39.
    • (2004) Diabetologia , vol.47 , pp. 31-39
    • Gastaldelli, A.1    Ferrannini, E.2    Miyazaki, Y.3
  • 22
    • 12244299450 scopus 로고    scopus 로고
    • Beta-Cell function in subjects spanning the range from normal glucose tolerance to overt diabetes: A new analysis
    • Ferrannini, E., Gastaldelli, A., Miyazaki, Y., et al,. (2005) beta-Cell function in subjects spanning the range from normal glucose tolerance to overt diabetes: a new analysis. Journal of Clinical Endocrinology and Metabolism, 90, 493-500.
    • (2005) Journal of Clinical Endocrinology and Metabolism , vol.90 , pp. 493-500
    • Ferrannini, E.1    Gastaldelli, A.2    Miyazaki, Y.3
  • 24
    • 0023850277 scopus 로고
    • Quantitative study of insulin secretion and clearance in normal and obese subjects
    • Polonsky, K.S., Given, B.D., Hirsch, L., et al,. (1988) Quantitative study of insulin secretion and clearance in normal and obese subjects. The Journal of clinical investigation, 81, 435-441.
    • (1988) The Journal of Clinical Investigation , vol.81 , pp. 435-441
    • Polonsky, K.S.1    Given, B.D.2    Hirsch, L.3
  • 25
    • 33745302884 scopus 로고    scopus 로고
    • The natural course of beta-cell function in nondiabetic and diabetic individuals: The Insulin Resistance Atherosclerosis Study
    • Festa, A., Williams, K., D'Agostino, R. Jr., et al,. (2006) The natural course of beta-cell function in nondiabetic and diabetic individuals: the Insulin Resistance Atherosclerosis Study. Diabetes, 55, 1114-1120.
    • (2006) Diabetes , vol.55 , pp. 1114-1120
    • Festa, A.1    Williams, K.2    D'Agostino, Jr.R.3
  • 26
    • 33845405222 scopus 로고    scopus 로고
    • Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy
    • Kahn, S.E., Haffner, S.M., Heise, M.A., et al,. (2006) Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy. New England Journal of Medicine, 355, 2427-2443.
    • (2006) New England Journal of Medicine , vol.355 , pp. 2427-2443
    • Kahn, S.E.1    Haffner, S.M.2    Heise, M.A.3
  • 27
    • 77954323314 scopus 로고    scopus 로고
    • The stunned beta cell: A brief history
    • Ferrannini, E., (2010) The stunned beta cell: a brief history. Cell Metabolism, 11, 349-352.
    • (2010) Cell Metabolism , vol.11 , pp. 349-352
    • Ferrannini, E.1
  • 28
    • 0037045845 scopus 로고    scopus 로고
    • Effect of 6-week course of glucagon-like peptide 1 on glycaemic control, insulin sensitivity, and beta-cell function in type 2 diabetes: A parallel-group study
    • Zander, M., Madsbad, S., Madsen, J.L., et al,. (2002) Effect of 6-week course of glucagon-like peptide 1 on glycaemic control, insulin sensitivity, and beta-cell function in type 2 diabetes: a parallel-group study. Lancet, 359, 824-830.
    • (2002) Lancet , vol.359 , pp. 824-830
    • Zander, M.1    Madsbad, S.2    Madsen, J.L.3
  • 29
    • 65949122087 scopus 로고    scopus 로고
    • One-year treatment with exenatide improves beta-cell function, compared with insulin glargine, in metformin-treated type 2 diabetic patients: A randomized, controlled trial
    • Bunck, M.C., Diamant, M., Corner, A., et al,. (2009) One-year treatment with exenatide improves beta-cell function, compared with insulin glargine, in metformin-treated type 2 diabetic patients: a randomized, controlled trial. Diabetes Care, 32, 762-768.
    • (2009) Diabetes Care , vol.32 , pp. 762-768
    • Bunck, M.C.1    Diamant, M.2    Corner, A.3
  • 30
    • 31044456099 scopus 로고    scopus 로고
    • Brain glucagon-like peptide-1 increases insulin secretion and muscle insulin resistance to favor hepatic glycogen storage
    • Knauf, C., Cani, P.D., Perrin, C., et al,. (2005) Brain glucagon-like peptide-1 increases insulin secretion and muscle insulin resistance to favor hepatic glycogen storage. The Journal of clinical investigation, 115, 3554-3563.
    • (2005) The Journal of Clinical Investigation , vol.115 , pp. 3554-3563
    • Knauf, C.1    Cani, P.D.2    Perrin, C.3
  • 31
    • 50949094723 scopus 로고    scopus 로고
    • Arcuate glucagon-like peptide 1 receptors regulate glucose homeostasis but not food intake
    • Sandoval, D.A., Bagnol, D., Woods, S.C., et al,. (2008) Arcuate glucagon-like peptide 1 receptors regulate glucose homeostasis but not food intake. Diabetes, 57, 2046-2054.
    • (2008) Diabetes , vol.57 , pp. 2046-2054
    • Sandoval, D.A.1    Bagnol, D.2    Woods, S.C.3
  • 32
    • 4043101702 scopus 로고    scopus 로고
    • Separate contribution of diabetes, total fat mass, and fat topography to glucose production, gluconeogenesis, and glycogenolysis
    • Gastaldelli, A., Miyazaki, Y., Pettiti, M., et al,. (2004) Separate contribution of diabetes, total fat mass, and fat topography to glucose production, gluconeogenesis, and glycogenolysis. Journal of Clinical Endocrinology and Metabolism, 89, 3914-3921.
    • (2004) Journal of Clinical Endocrinology and Metabolism , vol.89 , pp. 3914-3921
    • Gastaldelli, A.1    Miyazaki, Y.2    Pettiti, M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.